BCLI

BRAINSTORM CELL THERAPUTC

Delisted

BCLI was delisted on the 17th of July, 2025.

48 hedge funds and large institutions have $11M invested in BRAINSTORM CELL THERAPUTC in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 17 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

28% less capital invested

Capital invested by funds: $15.3M → $11M (-$4.3M)

65% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 17

Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.45M
Puts
$308K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.94M
2
$1.31M
3
$761K
4
$731K
5
$698K
6
$517K
7
$516K
8
$304K
9
$289K
10
$265K
11
$257K
12
$154K
13
$125K
14
$113K
15
$104K
16
$82K
17
$77K
18
$70K
19
$70K
20
$67K
21
$57K
22
$50K
23
$47K
24
$45K
25
$42K